95 related articles for article (PubMed ID: 14684331)
21. Structure and mechanism of carbonic anhydrase.
Lindskog S
Pharmacol Ther; 1997; 74(1):1-20. PubMed ID: 9336012
[TBL] [Abstract][Full Text] [Related]
22. Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity.
Pogacar Z; Johnson JL; Krenning L; De Conti G; Jochems F; Lieftink C; Velds A; Wardak L; Groot K; Schepers A; Wang L; Song JY; van de Ven M; van Tellingen O; Medema RH; Beijersbergen RL; Bernards R; Leite de Oliveira R
PLoS One; 2022; 17(9):e0273182. PubMed ID: 36067171
[TBL] [Abstract][Full Text] [Related]
23. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
Han T; Goralski M; Gaskill N; Capota E; Kim J; Ting TC; Xie Y; Williams NS; Nijhawan D
Science; 2017 Apr; 356(6336):. PubMed ID: 28302793
[TBL] [Abstract][Full Text] [Related]
24. Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids.
Aboukhatwa SM; Sidhom PA; Angeli A; Supuran CT; Tawfik HO
ACS Omega; 2023 Feb; 8(8):7666-7683. PubMed ID: 36872984
[TBL] [Abstract][Full Text] [Related]
25. Toxicity Assessment of an Anti-Cancer Drug of p-Toluene Sulfonamide in Zebrafish Larvae Based on Cardiovascular and Locomotion Activities.
Young AYW; Audira G; Saputra F; Alos HC; Aventurado CA; Lai YH; Vasquez RD; Hsiao CD; Hung CH
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008997
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids.
Auti PS; George G; Paul AT
RSC Adv; 2020 Nov; 10(68):41353-41392. PubMed ID: 35516563
[TBL] [Abstract][Full Text] [Related]
27. Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
Nijhuis A; Sikka A; Yogev O; Herendi L; Balcells C; Ma Y; Poon E; Eckold C; Valbuena GN; Xu Y; Liu Y; da Costa BM; Gruet M; Wickremesinghe C; Benito A; Kramer H; Montoya A; Carling D; Want EJ; Jamin Y; Chesler L; Keun HC
Nat Commun; 2022 Mar; 13(1):1380. PubMed ID: 35296644
[TBL] [Abstract][Full Text] [Related]
28. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.
Chen WC; To MD; Westcott PMK; Delrosario R; Kim IJ; Philips M; Tran Q; Bollam SR; Goodarzi H; Bayani N; Mirzoeva O; Balmain A
Nat Commun; 2021 Jul; 12(1):4288. PubMed ID: 34257283
[TBL] [Abstract][Full Text] [Related]
29. MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment.
Garbati P; Barbieri R; Cangelosi D; Zanon C; Costa D; Eva A; Thellung S; Calderoni M; Baldini F; Tonini GP; Modesto P; Florio T; Pagano A
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33153038
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of novel
Hussein EM; Al-Rooqi MM; Abd El-Galil SM; Ahmed SA
BMC Chem; 2019 Dec; 13(1):91. PubMed ID: 31384838
[TBL] [Abstract][Full Text] [Related]
31. Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides.
Meleddu R; Distinto S; Cottiglia F; Angius R; Gaspari M; Taverna D; Melis C; Angeli A; Bianco G; Deplano S; Fois B; Del Prete S; Capasso C; Alcaro S; Ortuso F; Yanez M; Supuran CT; Maccioni E
ACS Med Chem Lett; 2018 Oct; 9(10):1045-1050. PubMed ID: 30344915
[TBL] [Abstract][Full Text] [Related]
32. Crystallography and Its Impact on Carbonic Anhydrase Research.
Lomelino CL; Andring JT; McKenna R
Int J Med Chem; 2018; 2018():9419521. PubMed ID: 30302289
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel 5-chloro-
Galal AMF; Soltan MM; Ahmed ER; Hanna AG
Medchemcomm; 2018 Sep; 9(9):1511-1528. PubMed ID: 30288225
[TBL] [Abstract][Full Text] [Related]
34. Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.
Mboge MY; Kota A; McKenna R; Frost SC
Int J Med Chem; 2018; 2018():2906519. PubMed ID: 30112206
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Spectroscopic Characterization, and
Bouzina A; Bechlem K; Berredjem H; Belhani B; Becheker I; Lebreton J; Le Borgne M; Bouaziz Z; Marminon C; Berredjem M
Molecules; 2018 Jul; 23(7):. PubMed ID: 29996552
[TBL] [Abstract][Full Text] [Related]
36. Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site.
Singh S; Lomelino CL; Mboge MY; Frost SC; McKenna R
Molecules; 2018 Apr; 23(5):. PubMed ID: 29710858
[TBL] [Abstract][Full Text] [Related]
37. Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Assi R; Kantarjian HM; Kadia TM; Pemmaraju N; Jabbour E; Jain N; Daver N; Estrov Z; Uehara T; Owa T; Cortes JE; Borthakur G
Cancer; 2018 Jul; 124(13):2758-2765. PubMed ID: 29660836
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.
Akocak S; Lolak N; Vullo D; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1305-1312. PubMed ID: 29072105
[TBL] [Abstract][Full Text] [Related]
39. Diverse amide analogs of sulindac for cancer treatment and prevention.
Mathew B; Hobrath JV; Connelly MC; Kiplin Guy R; Reynolds RC
Bioorg Med Chem Lett; 2017 Oct; 27(20):4614-4621. PubMed ID: 28935266
[TBL] [Abstract][Full Text] [Related]
40. Rapid LC-MS Based High-Throughput Screening Method, Affording No False Positives or False Negatives, Identifies a New Inhibitor for Carbonic Anhydrase.
Imaduwage KP; Lakbub J; Go EP; Desaire H
Sci Rep; 2017 Sep; 7(1):10324. PubMed ID: 28871149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
